Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Capital Expenditures: 2013-2024

Historic Capital Expenditures for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $90.4 million.

  • Surgery Partners' Capital Expenditures fell 198.02% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year decrease of 56.12%. This contributed to the annual value of $90.4 million for FY2024, which is 180.18% up from last year.
  • According to the latest figures from FY2024, Surgery Partners' Capital Expenditures is $90.4 million, which was up 180.18% from $88.8 million recorded in FY2023.
  • Surgery Partners' 5-year Capital Expenditures high stood at $90.4 million for FY2024, and its period low was $42.9 million during FY2020.
  • Over the past 5 years, Surgery Partners' median Capital Expenditures value was $80.6 million (recorded in 2022), while the average stood at $72.1 million.
  • As far as peak fluctuations go, Surgery Partners' Capital Expenditures plummeted by 4171.2% in 2020, and later soared by 3993.06% in 2022.
  • Annual analysis of 5 years shows Surgery Partners' Capital Expenditures stood at $42.9 million in 2020, then soared by 34.27% to $57.6 million in 2021, then surged by 39.93% to $80.6 million in 2022, then increased by 10.17% to $88.8 million in 2023, then increased by 1.8% to $90.4 million in 2024.
  • Its Capital Expenditures stands at $90.4 million for FY2024, versus $88.8 million for FY2023 and $80.6 million for FY2022.